Can-Fite BioPharma Ltd. Depreciation and Amortization
Can-Fite BioPharma Ltd. (CANF) reported Depreciation and Amortization of $24.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-03-26
| Period end | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|
| 2025-12-31 | $24.00K 20-F · filed 2026-03-26 | |
| 2025-06-30 | $23.00K 6-K · filed 2025-08-28 | |
| 2024-12-31 | $7.00K 20-F · filed 2026-03-26 | |
| 2024-06-30 | $1.00K 6-K · filed 2025-08-28 | |
| 2023-12-31 | $15.00K 20-F · filed 2026-03-26 | |
| 2023-06-30 | $8.00K 6-K · filed 2024-08-29 | |
| 2022-12-31 | $14.00K 20-F · filed 2023-03-30 | |
| 2022-06-30 | $6.00K 6-K · filed 2023-08-31 | |
| 2021-12-31 | $14.00K 20-F · filed 2023-03-30 | |
| 2020-12-31 | $12.00K 20-F · filed 2023-03-30 | |
| 2019-12-31 | $14.00K 20-F · filed 2022-03-24 | |
| 2018-12-31 | $14.00K 20-F · filed 2021-03-25 |